| The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2 MV Huisman, KJ Rothman, M Paquette, C Teutsch, HC Diener, SJ Dubner, ... Journal of the American College of Cardiology 69 (7), 777-785, 2017 | 338 | 2017 |
| Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects B López, A González, N Hermida, F Valencia, E de Teresa, J Díez American Journal of Physiology-Heart and Circulatory Physiology 299 (1), H1-H9, 2010 | 302 | 2010 |
| Prevalencia de la insuficiencia cardiaca en la población general española mayor de 45 años. Estudio PRICE MA Sánchez, MGC Leiro, E de Teresa Galván, MJ Navarro, ... Revista Española de Cardiología 61 (10), 1041-1049, 2008 | 272 | 2008 |
| Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial J Delgado-Lista, JF Alcala-Diaz, JD Torres-Peña, GM Quintana-Navarro, ... The Lancet 399 (10338), 1876-1885, 2022 | 250 | 2022 |
| Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial J Bermejo, R Yotti, R García-Orta, PL Sánchez-Fernández, M Castaño, ... European Heart Journal 39 (15), 1255-1264, 2018 | 191 | 2018 |
| Prevalence of heart failure in the Spanish general population aged over 45 years. The PRICE Study MA Sánchez, MGC Leiro, E de Teresa Galván, MJ Navarro, ... Revista Española de Cardiología (English Edition) 61 (10), 1041-1049, 2008 | 184 | 2008 |
| Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF) M Stockburger, JJ Gómez-Doblas, G Lamas, J Alzueta, ... European journal of heart failure 13 (6), 633-641, 2011 | 128 | 2011 |
| Nuevos datos sobre la prevención secundaria del infarto de miocardio en España. Resultados del estudio PREVESE II JA de Velasco, J Cosín, JL López-Sendón, E de Teresa, M de Oya, ... Revista Española de Cardiología 55 (8), 801-809, 2002 | 127 | 2002 |
| Incidence, associated factors and evolution of non-severe functional mitral regurgitation in patients with severe aortic stenosis undergoing aortic valve replacement J Caballero-Borrego, JJ Gómez-Doblas, F Cabrera-Bueno, ... European journal of cardio-thoracic surgery 34 (1), 62-66, 2008 | 122 | 2008 |
| Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy … LM Blanco-Colio, JL Martín-Ventura, E de Teresa, C Farsang, A Gaw, ... American heart journal 153 (5), 881-888, 2007 | 107 | 2007 |
| La prevención secundaria del infarto de miocardio en España. Estudio PREVESE JA de Velasco, J Cosín, JLL Sendón, E de Teresa, M de Oya, JL Carrasco, ... Revista Española de Cardiología 50 (6), 406-415, 1997 | 107 | 1997 |
| microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1 up-regulation J Beaumont, B Lopez, N Hermida, B Schroen, G San José, S Heymans, ... Clinical science 126 (7), 497-506, 2014 | 101 | 2014 |
| An even more physiological pacing: changing the sequence of ventricular activation E de Teresa, JL Chamorro, LA Pulpón, C Ruiz, IR Bailón, J Alzueta, ... Cardiac Pacing: Proceedings of the VIIth World Symposium on Cardiac Pacing …, 1983 | 96 | 1983 |
| Factors predicting and having an impact on the need for a permanent pacemaker after CoreValve prosthesis implantation using the new Accutrak delivery catheter system AJ Muñoz-García, JM Hernández-García, MF Jiménez-Navarro, ... JACC: Cardiovascular Interventions 5 (5), 533-539, 2012 | 90 | 2012 |
| Beta-blocker therapy for dynamic left ventricular outflow tract obstruction induced by exercise F Cabrera-Bueno, JM García-Pinilla, JJ Gómez-Doblas, A Montiel-Trujillo, ... International journal of cardiology 117 (2), 222-226, 2007 | 87 | 2007 |
| Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST LM Blanco-Colio, JL Martín-Ventura, E de Teresa, C Farsang, A Gaw, ... Arteriosclerosis, thrombosis, and vascular biology 27 (1), 168-174, 2007 | 80 | 2007 |
| Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction N Fernández‐Arcás, JL Dieguez‐Lucena, E Muñoz‐Morán, ... Clinical genetics 60 (1), 52-57, 2001 | 78 | 2001 |
| Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes M Perán, JA Marchal, E López, M Jiménez-Navarro, H Boulaiz, ... Cytotherapy 12 (3), 332-337, 2010 | 76 | 2010 |
| Rehabilitación cardiaca postinfarto de miocardio en enfermos de bajo riesgo. Resultados de un programa de coordinación entre cardiología y atención primaria S Espinosa Caliani, JC Bravo Navas, R Collantes Rivera, ... Revista espanola de cardiologia 57 (1), 53-59, 2004 | 73 | 2004 |
| Persistence of secondary mitral regurgitation and response to cardiac resynchronization therapy F Cabrera-Bueno, MJ Molina-Mora, J Alzueta, J Pena-Hernandez, ... European Journal of Echocardiography 11 (2), 131-137, 2010 | 72 | 2010 |
